Track topics on Twitter Track topics that are important to you
BioWa’s POTELLIGENT™ service significantly improve the probability of successful mAb development by directly addressing many of the weaknesses that have led to previous failures. More specifically, POTELLIGENT™ efficiently increases the potency and efficacy of your monoclonal antibodies, so that:
212 Carnegie Center Suite 101
United States of America
SummaryBiowa Inc BioWa, a subsidiary of Kyowa Hakko Kirin Co Ltd KHK, is a science and technology company that provides out licensing of therapeutic antibody technologies of KHK. The company also deve...
BioWa’s POTELLIGENT™ service significantly improve the probability of successful mAb development by directly addressing many of the weaknesses that have led to previous failures. More specifically...
IMUC is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The Company recently started a Phase II ...
We have published hundreds of BioWa news stories on BioPortfolio along with dozens of BioWa Clinical Trials and PubMed Articles about BioWa for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioWa Companies in our database. You can also find out about relevant BioWa Drugs and Medications on this site too.